ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Nervous System Markers Market Research Report 2025
Published Date: February 2025
|
Report Code: QYRE-Auto-10L10404
Home | Market Reports | Health| Health Foundations & Medical Research
Global Nervous System Markers Market Research Report 2022
BUY CHAPTERS

Global Nervous System Markers Market Research Report 2025

Code: QYRE-Auto-10L10404
Report
February 2025
Pages:72
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Athena Diagnostics
Myriad RBM
Qiagen NV
Thermo Fisher Scientific

Nervous System Markers Market Size

The global market for Nervous System Markers was valued at US$ 598 million in the year 2024 and is projected to reach a revised size of US$ 900 million by 2031, growing at a CAGR of 6.1% during the forecast period.

Nervous System Markers Market

Nervous System Markers Market

A major percentage of world population is affected by neurological disorders, this in turn is causing major disabilities globally. Due to the high incidence of neurological disorders, there is the need for biomarkers as biomarkers measure biological states and are used for indication of both pathogenic as well as normal biological process in terms of therapeutic intervention. Biomarkers can also be utilized in combination for accessing the state of the disease of an individual.
According to the "Global Use of Medicines 2023" released by the IQVIA Institute, the global drug expenditure in 2022 will be approximately US$1.48 trillion (excluding costs related to COVID vaccines and therapies), and it is predicted that it will grow at a rate of 3%-6% in the next few years. In terms of regional development trends, high-income countries such as Western Europe, North America, and Japan are expected to experience slower growth in the next few years due to already high per capita usage, while growth markets such as Asia, Latin America, and Eastern Europe are expected to grow strongly. In terms of drug expenditure, China"s drug expenditure in 2022 will be about 166 billion US dollars. It is expected that the expenditure on medicines will only increase in the next few years: From the perspective of demand, the trend of population aging, the increase of residents’ wealth and the improvement of health awareness will drive the demand for medicines; from the perspective of national strategy, in 2016 , the State Council issued the "Healthy China 2030" Planning Outline, and "Healthy China" has risen to a national strategy; from the perspective of industry policy, it has experienced the uncertainty brought about by the initial stage of medical reform, the implementation of the centralized procurement policy and the expansion of the drug reimbursement catalog The update will gradually achieve a dynamic balance of multiple goals such as promoting innovation, stabilizing supply, and reducing the burden on the masses.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Nervous System Markers, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Nervous System Markers.
The Nervous System Markers market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Nervous System Markers market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Nervous System Markers manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Nervous System Markers Market Report

Report Metric Details
Report Name Nervous System Markers Market
Accounted market size in year US$ 598 million
Forecasted market size in 2031 US$ 900 million
CAGR 6.1%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • Imaging Biomarkers
  • Metabolomics Biomarkers
  • Proteomic Biomarkers
  • Genomics Biomarkers
Segment by Application
  • Spinal Muscular Atrophy (SMA)
  • Multiple Sclerosis
  • Depression
  • Schizophrenia
  • Huntington's Disease
  • Parkinson's Disease
  • Alzheimer's Disease
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Athena Diagnostics, Myriad RBM, QIAGEN, Thermo Fisher Scientific
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Nervous System Markers manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Nervous System Markers in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Nervous System Markers Market growing?

Ans: The Nervous System Markers Market witnessing a CAGR of 6.1% during the forecast period 2025-2031.

What is the Nervous System Markers Market size in 2031?

Ans: The Nervous System Markers Market size in 2031 will be US$ 900 million.

Who are the main players in the Nervous System Markers Market report?

Ans: The main players in the Nervous System Markers Market are Athena Diagnostics, Myriad RBM, QIAGEN, Thermo Fisher Scientific

What are the Application segmentation covered in the Nervous System Markers Market report?

Ans: The Applications covered in the Nervous System Markers Market report are Spinal Muscular Atrophy (SMA), Multiple Sclerosis, Depression, Schizophrenia, Huntington's Disease, Parkinson's Disease, Alzheimer's Disease

What are the Type segmentation covered in the Nervous System Markers Market report?

Ans: The Types covered in the Nervous System Markers Market report are Imaging Biomarkers, Metabolomics Biomarkers, Proteomic Biomarkers, Genomics Biomarkers

1 Nervous System Markers Market Overview
1.1 Product Definition
1.2 Nervous System Markers by Type
1.2.1 Global Nervous System Markers Market Value Comparison by Type (2024 VS 2031)
1.2.2 Imaging Biomarkers
1.2.3 Metabolomics Biomarkers
1.2.4 Proteomic Biomarkers
1.2.5 Genomics Biomarkers
1.3 Nervous System Markers by Application
1.3.1 Global Nervous System Markers Market Value by Application (2024 VS 2031)
1.3.2 Spinal Muscular Atrophy (SMA)
1.3.3 Multiple Sclerosis
1.3.4 Depression
1.3.5 Schizophrenia
1.3.6 Huntington's Disease
1.3.7 Parkinson's Disease
1.3.8 Alzheimer's Disease
1.4 Global Nervous System Markers Market Size Estimates and Forecasts
1.4.1 Global Nervous System Markers Revenue 2020-2031
1.4.2 Global Nervous System Markers Sales 2020-2031
1.4.3 Global Nervous System Markers Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Nervous System Markers Market Competition by Manufacturers
2.1 Global Nervous System Markers Sales Market Share by Manufacturers (2020-2025)
2.2 Global Nervous System Markers Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Nervous System Markers Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Nervous System Markers, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Nervous System Markers, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Nervous System Markers, Product Type & Application
2.7 Global Key Manufacturers of Nervous System Markers, Date of Enter into This Industry
2.8 Global Nervous System Markers Market Competitive Situation and Trends
2.8.1 Global Nervous System Markers Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Nervous System Markers Players Market Share by Revenue
2.8.3 Global Nervous System Markers Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Nervous System Markers Market Scenario by Region
3.1 Global Nervous System Markers Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Nervous System Markers Sales by Region: 2020-2031
3.2.1 Global Nervous System Markers Sales by Region: 2020-2025
3.2.2 Global Nervous System Markers Sales by Region: 2026-2031
3.3 Global Nervous System Markers Revenue by Region: 2020-2031
3.3.1 Global Nervous System Markers Revenue by Region: 2020-2025
3.3.2 Global Nervous System Markers Revenue by Region: 2026-2031
3.4 North America Nervous System Markers Market Facts & Figures by Country
3.4.1 North America Nervous System Markers Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Nervous System Markers Sales by Country (2020-2031)
3.4.3 North America Nervous System Markers Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Nervous System Markers Market Facts & Figures by Country
3.5.1 Europe Nervous System Markers Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Nervous System Markers Sales by Country (2020-2031)
3.5.3 Europe Nervous System Markers Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Nervous System Markers Market Facts & Figures by Region
3.6.1 Asia Pacific Nervous System Markers Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Nervous System Markers Sales by Region (2020-2031)
3.6.3 Asia Pacific Nervous System Markers Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Nervous System Markers Market Facts & Figures by Country
3.7.1 Latin America Nervous System Markers Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Nervous System Markers Sales by Country (2020-2031)
3.7.3 Latin America Nervous System Markers Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Nervous System Markers Market Facts & Figures by Country
3.8.1 Middle East and Africa Nervous System Markers Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Nervous System Markers Sales by Country (2020-2031)
3.8.3 Middle East and Africa Nervous System Markers Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Nervous System Markers Sales by Type (2020-2031)
4.1.1 Global Nervous System Markers Sales by Type (2020-2025)
4.1.2 Global Nervous System Markers Sales by Type (2026-2031)
4.1.3 Global Nervous System Markers Sales Market Share by Type (2020-2031)
4.2 Global Nervous System Markers Revenue by Type (2020-2031)
4.2.1 Global Nervous System Markers Revenue by Type (2020-2025)
4.2.2 Global Nervous System Markers Revenue by Type (2026-2031)
4.2.3 Global Nervous System Markers Revenue Market Share by Type (2020-2031)
4.3 Global Nervous System Markers Price by Type (2020-2031)
5 Segment by Application
5.1 Global Nervous System Markers Sales by Application (2020-2031)
5.1.1 Global Nervous System Markers Sales by Application (2020-2025)
5.1.2 Global Nervous System Markers Sales by Application (2026-2031)
5.1.3 Global Nervous System Markers Sales Market Share by Application (2020-2031)
5.2 Global Nervous System Markers Revenue by Application (2020-2031)
5.2.1 Global Nervous System Markers Revenue by Application (2020-2025)
5.2.2 Global Nervous System Markers Revenue by Application (2026-2031)
5.2.3 Global Nervous System Markers Revenue Market Share by Application (2020-2031)
5.3 Global Nervous System Markers Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Athena Diagnostics
6.1.1 Athena Diagnostics Company Information
6.1.2 Athena Diagnostics Description and Business Overview
6.1.3 Athena Diagnostics Nervous System Markers Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Athena Diagnostics Nervous System Markers Product Portfolio
6.1.5 Athena Diagnostics Recent Developments/Updates
6.2 Myriad RBM
6.2.1 Myriad RBM Company Information
6.2.2 Myriad RBM Description and Business Overview
6.2.3 Myriad RBM Nervous System Markers Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Myriad RBM Nervous System Markers Product Portfolio
6.2.5 Myriad RBM Recent Developments/Updates
6.3 QIAGEN
6.3.1 QIAGEN Company Information
6.3.2 QIAGEN Description and Business Overview
6.3.3 QIAGEN Nervous System Markers Sales, Revenue and Gross Margin (2020-2025)
6.3.4 QIAGEN Nervous System Markers Product Portfolio
6.3.5 QIAGEN Recent Developments/Updates
6.4 Thermo Fisher Scientific
6.4.1 Thermo Fisher Scientific Company Information
6.4.2 Thermo Fisher Scientific Description and Business Overview
6.4.3 Thermo Fisher Scientific Nervous System Markers Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Thermo Fisher Scientific Nervous System Markers Product Portfolio
6.4.5 Thermo Fisher Scientific Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Nervous System Markers Industry Chain Analysis
7.2 Nervous System Markers Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Nervous System Markers Production Mode & Process Analysis
7.4 Nervous System Markers Sales and Marketing
7.4.1 Nervous System Markers Sales Channels
7.4.2 Nervous System Markers Distributors
7.5 Nervous System Markers Customer Analysis
8 Nervous System Markers Market Dynamics
8.1 Nervous System Markers Industry Trends
8.2 Nervous System Markers Market Drivers
8.3 Nervous System Markers Market Challenges
8.4 Nervous System Markers Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Athena Diagnostics
Myriad RBM
Qiagen NV
Thermo Fisher Scientific
List of Tables
 Table 1. Global Nervous System Markers Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Nervous System Markers Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Nervous System Markers Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Nervous System Markers Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Nervous System Markers Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Nervous System Markers Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Nervous System Markers Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Nervous System Markers Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Nervous System Markers, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Nervous System Markers, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Nervous System Markers, Product Type & Application
 Table 12. Global Key Manufacturers of Nervous System Markers, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Nervous System Markers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nervous System Markers as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Nervous System Markers Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Nervous System Markers Sales by Region (2020-2025) & (K Units)
 Table 18. Global Nervous System Markers Sales Market Share by Region (2020-2025)
 Table 19. Global Nervous System Markers Sales by Region (2026-2031) & (K Units)
 Table 20. Global Nervous System Markers Sales Market Share by Region (2026-2031)
 Table 21. Global Nervous System Markers Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Nervous System Markers Revenue Market Share by Region (2020-2025)
 Table 23. Global Nervous System Markers Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Nervous System Markers Revenue Market Share by Region (2026-2031)
 Table 25. North America Nervous System Markers Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Nervous System Markers Sales by Country (2020-2025) & (K Units)
 Table 27. North America Nervous System Markers Sales by Country (2026-2031) & (K Units)
 Table 28. North America Nervous System Markers Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Nervous System Markers Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Nervous System Markers Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Nervous System Markers Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Nervous System Markers Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Nervous System Markers Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Nervous System Markers Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Nervous System Markers Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Nervous System Markers Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Nervous System Markers Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Nervous System Markers Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Nervous System Markers Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Nervous System Markers Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Nervous System Markers Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Nervous System Markers Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Nervous System Markers Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Nervous System Markers Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Nervous System Markers Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Nervous System Markers Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Nervous System Markers Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Nervous System Markers Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Nervous System Markers Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Nervous System Markers Sales (K Units) by Type (2020-2025)
 Table 51. Global Nervous System Markers Sales (K Units) by Type (2026-2031)
 Table 52. Global Nervous System Markers Sales Market Share by Type (2020-2025)
 Table 53. Global Nervous System Markers Sales Market Share by Type (2026-2031)
 Table 54. Global Nervous System Markers Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Nervous System Markers Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Nervous System Markers Revenue Market Share by Type (2020-2025)
 Table 57. Global Nervous System Markers Revenue Market Share by Type (2026-2031)
 Table 58. Global Nervous System Markers Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Nervous System Markers Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Nervous System Markers Sales (K Units) by Application (2020-2025)
 Table 61. Global Nervous System Markers Sales (K Units) by Application (2026-2031)
 Table 62. Global Nervous System Markers Sales Market Share by Application (2020-2025)
 Table 63. Global Nervous System Markers Sales Market Share by Application (2026-2031)
 Table 64. Global Nervous System Markers Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Nervous System Markers Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Nervous System Markers Revenue Market Share by Application (2020-2025)
 Table 67. Global Nervous System Markers Revenue Market Share by Application (2026-2031)
 Table 68. Global Nervous System Markers Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Nervous System Markers Price (US$/Unit) by Application (2026-2031)
 Table 70. Athena Diagnostics Company Information
 Table 71. Athena Diagnostics Description and Business Overview
 Table 72. Athena Diagnostics Nervous System Markers Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Athena Diagnostics Nervous System Markers Product
 Table 74. Athena Diagnostics Recent Developments/Updates
 Table 75. Myriad RBM Company Information
 Table 76. Myriad RBM Description and Business Overview
 Table 77. Myriad RBM Nervous System Markers Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Myriad RBM Nervous System Markers Product
 Table 79. Myriad RBM Recent Developments/Updates
 Table 80. QIAGEN Company Information
 Table 81. QIAGEN Description and Business Overview
 Table 82. QIAGEN Nervous System Markers Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. QIAGEN Nervous System Markers Product
 Table 84. QIAGEN Recent Developments/Updates
 Table 85. Thermo Fisher Scientific Company Information
 Table 86. Thermo Fisher Scientific Description and Business Overview
 Table 87. Thermo Fisher Scientific Nervous System Markers Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Thermo Fisher Scientific Nervous System Markers Product
 Table 89. Thermo Fisher Scientific Recent Developments/Updates
 Table 90. Key Raw Materials Lists
 Table 91. Raw Materials Key Suppliers Lists
 Table 92. Nervous System Markers Distributors List
 Table 93. Nervous System Markers Customers List
 Table 94. Nervous System Markers Market Trends
 Table 95. Nervous System Markers Market Drivers
 Table 96. Nervous System Markers Market Challenges
 Table 97. Nervous System Markers Market Restraints
 Table 98. Research Programs/Design for This Report
 Table 99. Key Data Information from Secondary Sources
 Table 100. Key Data Information from Primary Sources
 Table 101. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Nervous System Markers
 Figure 2. Global Nervous System Markers Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Nervous System Markers Market Share by Type: 2024 & 2031
 Figure 4. Imaging Biomarkers Product Picture
 Figure 5. Metabolomics Biomarkers Product Picture
 Figure 6. Proteomic Biomarkers Product Picture
 Figure 7. Genomics Biomarkers Product Picture
 Figure 8. Global Nervous System Markers Market Value by Application (2020-2031) & (US$ Million)
 Figure 9. Global Nervous System Markers Market Share by Application: 2024 & 2031
 Figure 10. Spinal Muscular Atrophy (SMA)
 Figure 11. Multiple Sclerosis
 Figure 12. Depression
 Figure 13. Schizophrenia
 Figure 14. Huntington's Disease
 Figure 15. Parkinson's Disease
 Figure 16. Alzheimer's Disease
 Figure 17. Global Nervous System Markers Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 18. Global Nervous System Markers Market Size (2020-2031) & (US$ Million)
 Figure 19. Global Nervous System Markers Sales (2020-2031) & (K Units)
 Figure 20. Global Nervous System Markers Average Price (US$/Unit) & (2020-2031)
 Figure 21. Nervous System Markers Report Years Considered
 Figure 22. Nervous System Markers Sales Share by Manufacturers in 2024
 Figure 23. Global Nervous System Markers Revenue Share by Manufacturers in 2024
 Figure 24. Global 5 and 10 Largest Nervous System Markers Players: Market Share by Revenue in Nervous System Markers in 2024
 Figure 25. Nervous System Markers Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 26. Global Nervous System Markers Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 27. North America Nervous System Markers Sales Market Share by Country (2020-2031)
 Figure 28. North America Nervous System Markers Revenue Market Share by Country (2020-2031)
 Figure 29. U.S. Nervous System Markers Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Canada Nervous System Markers Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Europe Nervous System Markers Sales Market Share by Country (2020-2031)
 Figure 32. Europe Nervous System Markers Revenue Market Share by Country (2020-2031)
 Figure 33. Germany Nervous System Markers Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. France Nervous System Markers Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. U.K. Nervous System Markers Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. Italy Nervous System Markers Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. Russia Nervous System Markers Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Asia Pacific Nervous System Markers Sales Market Share by Region (2020-2031)
 Figure 39. Asia Pacific Nervous System Markers Revenue Market Share by Region (2020-2031)
 Figure 40. China Nervous System Markers Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Japan Nervous System Markers Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. South Korea Nervous System Markers Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. India Nervous System Markers Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Australia Nervous System Markers Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Taiwan Nervous System Markers Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Indonesia Nervous System Markers Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Thailand Nervous System Markers Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Malaysia Nervous System Markers Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Philippines Nervous System Markers Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Latin America Nervous System Markers Sales Market Share by Country (2020-2031)
 Figure 51. Latin America Nervous System Markers Revenue Market Share by Country (2020-2031)
 Figure 52. Mexico Nervous System Markers Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Brazil Nervous System Markers Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. Argentina Nervous System Markers Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 55. Middle East and Africa Nervous System Markers Sales Market Share by Country (2020-2031)
 Figure 56. Middle East and Africa Nervous System Markers Revenue Market Share by Country (2020-2031)
 Figure 57. Turkey Nervous System Markers Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 58. Saudi Arabia Nervous System Markers Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 59. U.A.E Nervous System Markers Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 60. Global Sales Market Share of Nervous System Markers by Type (2020-2031)
 Figure 61. Global Revenue Market Share of Nervous System Markers by Type (2020-2031)
 Figure 62. Global Nervous System Markers Price (US$/Unit) by Type (2020-2031)
 Figure 63. Global Sales Market Share of Nervous System Markers by Application (2020-2031)
 Figure 64. Global Revenue Market Share of Nervous System Markers by Application (2020-2031)
 Figure 65. Global Nervous System Markers Price (US$/Unit) by Application (2020-2031)
 Figure 66. Nervous System Markers Value Chain
 Figure 67. Channels of Distribution (Direct Vs Distribution)
 Figure 68. Bottom-up and Top-down Approaches for This Report
 Figure 69. Data Triangulation
 Figure 70. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Seventh Sense AI

SIMILAR REPORTS

Global Central Nervous System Biomarkers Market Insights Forecast to 2030
Global Neurological Devices Market Research Report 2024
Global Nervous System Chemicals Market Research Report 2024
Global Neurologic Disorders Therapeutics Market Insights Forecast to 2030
Neuroscience Antibody Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Neuroscience Market Size Manufacturers Supply Chain Sales Channel and Clients 2024 2030
Global Neuronal Markers Market Research Report 2025
Neuroscience Devices Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Neuroscience Equipment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Neuroscience Medical Devices Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Neurological Biomarkers for Alzheimer s and Parkinson s Diseases Market Research Report 2025
Global Brain Biomarker Market Research Report 2024
Global Neurological Disorder Diagnostics Market Research Report 2024
Global Biomarker Detection Systems Market Research Report 2024
Medical Biomarkers Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Drugs for Central Nervous System Diseases Market Insights Forecast to 2030
Global Neurodiagnostic System Market Research Report 2024
Traumatic Brain Injury TBI Testing Biomarkers Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Digital Nervous System Market Research Report 2024
Global Biomarker Market Research Report 2024

RELATED REPORTS

Global Liraglutide Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

120 Pages
Type: Report
Code: QYRE-Auto-29O4198
Fri Mar 21 00:00:00 UTC 2025

Add to Cart

Global Mesenchymal Stem Cell Medium Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-10X13372
Fri Mar 21 00:00:00 UTC 2025

Add to Cart

Global Vascular Endothelial Growth Factor Detection Kits Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-7D19343
Fri Mar 14 00:00:00 UTC 2025

Add to Cart

Global Clinical Digital Pathology Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-33F15637
Thu Mar 13 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions